Congratulations to Lyla on her newly accepted paper to AACR’s Molecular Cancer Research entitled CBF-Beta Mitigates PI3K-Alpha–Specific Inhibitor Killing through PIM1 in PIK3CA-Mutant Gastric Cancer. This is great research highlighting the mechanisms of resistance to small molecule inhibitors in EBV-associated gastric cancer. Check out the paper here.
